🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This Phase Ib/II, open-label, multicenter trial is designed to evaluate the...
Status
Terminated
Location
Multiple Locations
Start Date
2006-06
Trial ID
NCT00400764
Treatments Being Tested
This is a Phase 1 study evaluating the safety of ABT-263 administered in co...
Status
Completed
Location
University of Arizona Cancer Center - North Campus /ID# 16721
Start Date
2009-07-21
Trial ID
NCT00788684
This Phase I Clinical Study assessed the Safety, Tolerability, Pharmacokine...
Status
Recruiting
Location
The First Affiliated Hospital of Zhengzhou University
Start Date
2023-03-02
Trial ID
NCT05668403
The purpose of this study is to determine whether rituximab is effective in...
Status
Completed
Location
Cochin Hospital
Start Date
2013-04-09
Trial ID
NCT01748084
Treatments Being Tested
The purpose is to identify a dose of SB-485232 which is safe, tolerable and...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-07-31
Trial ID
NCT00500058
This phase I trial studies the best dose and how well bendamustine works wi...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2009-02-17
Trial ID
NCT00880815
This is an open label clinical study: Phase Ia is a dose escalation phase, ...
Status
Recruiting
Location
The First Affiliated Hospital, School of Medicine, Zhejiang University
Start Date
2025-07-01
Trial ID
NCT07073833
Treatments Being Tested
This phase II trial studies how well a dose adjusted regimen consisting of ...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2015-01-14
Trial ID
NCT02199184
This phase II trial tests whether mosunetuzumab and/or polatuzumab vedotin ...
Status
Recruiting
Location
Banner University Medical Center - Tucson
Start Date
2023-06-12
Trial ID
NCT05633615
This is a multicenter, randomized, double-blind, parallel group study to co...
Status
Terminated
Location
First Hospital of Shanxi Medical University
Start Date
2018-11-16
Trial ID
NCT03670888